Received Mar 21, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| TDAP | TDAP (BOOSTRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | L5229 | IM / RA |
Patient received additional dose of Boostrix on 3/20/2025, previous dose was on 5/15/2024. CDC guidelines not met of 8-10 year apart from 1st dose. Patient arm was sore but no other symptoms.
None
None
Sulfa Drugs
None